Medistim ASA Cash Flow Conversion Efficiency
Medistim ASA cash flow conversion efficiency. Based on the latest financial reports, Medistim ASA (MEDI) has a cash flow conversion efficiency ratio of 0.098x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Nkr37.65 Million ≈ $3.96 Million USD) by net assets (Nkr383.81 Million ≈ $40.39 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of Medistim ASA for the company's overall valuation and market capitalisation.
Cash Flow Conversion Efficiency of Medistim ASA (2004–2024)
Cash flow conversion efficiency of Medistim ASA from 2004 to 2024. This chart illustrates how Medistim ASA's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Medistim ASA (MEDI) stock price for real-time trading data and today's change.
Medistim ASA Cash Flow Conversion Ratio Explained
Medistim ASA cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Medistim ASA Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Medistim ASA ranked by their cash flow conversion efficiency. Review free cash flow generation of Medistim ASA to assess how much free cash flow the company generates relative to operating cash flow.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Jiangsu Chuanzhiboke Education Tech
SHE:003032
|
0.024x |
|
Ningbo Techmation Co Ltd
SHG:603015
|
-0.006x |
|
Ares Acquisition Corporation II
NYSE:AACT
|
-0.003x |
|
Zhejiang Jasan Holding Group Co Ltd
SHG:603558
|
0.057x |
|
ShaoYang Victor Hydraulics Co.Ltd
SHE:301079
|
N/A |
|
Nuh Cimento Sanayi AS
IS:NUHCM
|
0.028x |
|
Anshan Hifichem Co Ltd
SHE:300758
|
0.020x |
|
ADENTRA INC.
F:UQ0
|
-0.009x |
Annual Cash Flow Conversion Efficiency for Medistim ASA (2004–2024)
The table below shows the annual cash flow conversion efficiency of Medistim ASA from 2004 to 2024. Also see Medistim ASA asset portfolio for a full breakdown of the balance sheet.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Nkr436.61 Million ≈ $45.94 Million |
Nkr143.10 Million ≈ $15.06 Million |
0.328x | +15.23% |
| 2023-12-31 | Nkr397.94 Million ≈ $41.87 Million |
Nkr113.19 Million ≈ $11.91 Million |
0.284x | -8.70% |
| 2022-12-31 | Nkr367.69 Million ≈ $38.69 Million |
Nkr114.56 Million ≈ $12.05 Million |
0.312x | -25.59% |
| 2021-12-31 | Nkr306.05 Million ≈ $32.21 Million |
Nkr128.14 Million ≈ $13.48 Million |
0.419x | +45.06% |
| 2020-12-31 | Nkr256.85 Million ≈ $27.03 Million |
Nkr74.13 Million ≈ $7.80 Million |
0.289x | -14.95% |
| 2019-12-31 | Nkr236.86 Million ≈ $24.92 Million |
Nkr80.38 Million ≈ $8.46 Million |
0.339x | +25.73% |
| 2018-12-31 | Nkr206.71 Million ≈ $21.75 Million |
Nkr55.79 Million ≈ $5.87 Million |
0.270x | -17.83% |
| 2017-12-31 | Nkr182.98 Million ≈ $19.26 Million |
Nkr60.10 Million ≈ $6.32 Million |
0.328x | +79.69% |
| 2016-12-31 | Nkr166.70 Million ≈ $17.54 Million |
Nkr30.47 Million ≈ $3.21 Million |
0.183x | -36.08% |
| 2015-12-31 | Nkr156.16 Million ≈ $16.43 Million |
Nkr44.66 Million ≈ $4.70 Million |
0.286x | -18.72% |
| 2014-12-31 | Nkr139.10 Million ≈ $14.64 Million |
Nkr48.94 Million ≈ $5.15 Million |
0.352x | +64.32% |
| 2013-12-31 | Nkr121.64 Million ≈ $12.80 Million |
Nkr26.04 Million ≈ $2.74 Million |
0.214x | -6.06% |
| 2012-12-31 | Nkr115.17 Million ≈ $12.12 Million |
Nkr26.25 Million ≈ $2.76 Million |
0.228x | -1.22% |
| 2011-12-31 | Nkr106.89 Million ≈ $11.25 Million |
Nkr24.66 Million ≈ $2.60 Million |
0.231x | -33.24% |
| 2010-12-31 | Nkr107.83 Million ≈ $11.35 Million |
Nkr37.27 Million ≈ $3.92 Million |
0.346x | +12.06% |
| 2009-12-31 | Nkr106.29 Million ≈ $11.19 Million |
Nkr32.78 Million ≈ $3.45 Million |
0.308x | +10.02% |
| 2008-12-31 | Nkr95.46 Million ≈ $10.05 Million |
Nkr26.76 Million ≈ $2.82 Million |
0.280x | +26.46% |
| 2007-12-31 | Nkr93.83 Million ≈ $9.87 Million |
Nkr20.80 Million ≈ $2.19 Million |
0.222x | -5.17% |
| 2006-12-31 | Nkr74.06 Million ≈ $7.79 Million |
Nkr17.31 Million ≈ $1.82 Million |
0.234x | +5.83% |
| 2005-12-31 | Nkr67.41 Million ≈ $7.09 Million |
Nkr14.89 Million ≈ $1.57 Million |
0.221x | +152.67% |
| 2004-12-31 | Nkr61.71 Million ≈ $6.49 Million |
Nkr5.39 Million ≈ $567.71K |
0.087x | -- |
About Medistim ASA
Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in… Read more